(-0.07%) 5 465.67 points
(0.07%) 39 140 points
(0.17%) 17 747 points
(0.04%) $80.86
(-5.04%) $2.62
(-0.79%) $2 312.30
(-0.10%) $28.84
(3.28%) $1 018.80
(0.34%) $0.936
(0.75%) $10.68
(0.50%) $0.792
(-0.27%) $87.25
3.45% $ 1.045
Live Chart Being Loaded With Signals
Oncolytics Biotech Inc., a development-stage biopharmaceutical company, focuses on the discovery and development of pharmaceutical products for the treatment of cancer...
Stats | |
---|---|
Volumen de hoy | 177 065 |
Volumen promedio | 221 306 |
Capitalización de mercado | 79.27M |
EPS | $-0.0536 ( Q4 | 2024-03-12 ) |
Próxima fecha de ganancias | ( $-0.0800 ) 2024-08-12 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E |
-3.60 (Sector) 42.63 (Industry) 24.32 |
ATR14 | $0.00600 (0.57%) |
Volumen Correlación
Oncolytics Biotech Inc Correlación
10 Correlaciones Más Negativas |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Oncolytics Biotech Inc Correlación - Moneda/Commodity
Oncolytics Biotech Inc Finanzas
Annual | 2023 |
Ingresos: | $0 |
Beneficio Bruto: | $-403 000 (0.00 %) |
EPS: | $-0.410 |
FY | 2023 |
Ingresos: | $0 |
Beneficio Bruto: | $-403 000 (0.00 %) |
EPS: | $-0.410 |
FY | 2022 |
Ingresos: | $0 |
Beneficio Bruto: | $-392 000 (0.00 %) |
EPS: | $-0.430 |
FY | 2021 |
Ingresos: | $0.00 |
Beneficio Bruto: | $0.00 (0.00 %) |
EPS: | $-0.652 |
Financial Reports:
No articles found.
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Oncolytics Biotech Inc
Oncolytics Biotech Inc., a development-stage biopharmaceutical company, focuses on the discovery and development of pharmaceutical products for the treatment of cancer. Its lead product is pelareorep, an intravenously delivered immunotherapeutic agent for the treatment of solid tumors and hematological malignancies. Oncolytics Biotech Inc. has a co-development agreement with Merck KGaA and Pfizer Inc. to co-develop pelareorep in combination with paclitaxel and avelumab, a human anti-PD-L1 antibody for the treatment of hormone receptor-positive/human epidermal growth factor 2-negative metastatic breast cancer; and PrECOG LLC. The company was incorporated in 1998 and is headquartered in Calgary, Canada.
Acerca de Señales en Vivo
Las señales en vivo presentadas en esta página ayudan a determinar cuándo COMPRAR o VENDER NA. Las señales tienen un retraso de más de 1 minuto; como todas las señales del mercado, existe la posibilidad de error o errores.
Las señales de trading en vivo no son definitivas y getagraph.com no asume ninguna responsabilidad por cualquier acción tomada sobre estas señales, como se describe en los Términos de Uso. Las señales se basan en una amplia gama de indicadores de análisis técnico